Back

Discussion.

7 April 2022 (16:45 - 16:55)
Organised by:
Congress Presentation Part of: Cardiovascular risk reduction beyond statin therapy: exploring the role of icosapent ethyl Treatment Open Access ESC Preventive Cardiology 2022

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor U. Laufs (Leipzig, DE)
Slides
Presentation thumbnail
Assessing residual cardiovascular risk in patients already treated with statin therapy.
Professor A. Zambon (Padua, IT)
Video
Presentation thumbnail
Exploring the role of icosapent ethyl based on current clinical evidence.
Professor J. Jukema (Leiden, NL)
Video
Presentation thumbnail
Icosapent ethyl: what are the most likely mechanisms of benefit?
Professor C. Packard (Glasgow, GB)
Video

Access the full session

Session thumbnail
Cardiovascular risk reduction beyond statin therapy: exploring the role of icosapent ethyl
Video

The Event

Event poster

ESC Preventive Cardiology 2022

7 April 2022 16:45 CET
You may be interested in
thumbnail
Congress Presentation
Discussion.
26 August 2022
thumbnail
Congress Session
Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?
20 May 2023
thumbnail
Congress Session
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases: Ask the Guidelines Task Force
2 September 2024
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources